Burçak Vural
Istanbul University
35 Papers
310 Citations
Burçak Vural is an academic researcher from Istanbul University. The author has contributed to research in topics: Medicine & Turkish population. The author has an hindex of 12, co-authored 34 publications.
Chat about Author
Papers
•Journal Article
Identification of point mutations in 41 unrelated patients affected with Menkes disease.
TL;DR: Genomic DNA of 41 unrelated patients affected with the classical severe form of Menkes disease was investigated for point mutations in the ATP7A gene, and five alterations were observed within the 6-bp sequence at the splice-donor site of intron 8, which would be predicted to affect the efficiency of splicing of exon 8.
104
Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome.
Burçak Vural,Fatmahan Atalar,Cavlan Ciftci,Ayse Demirkan,Belgin Susleyici-Duman,Demet Günay,Belhhan Akpinar,Ertan Sagbas,Ugur Ozbek,Ahmet Sevim Buyukdevrim +9 more
TL;DR: It is shown for the first time that human epicardial adipose and ascending aorta tissues express fatty-acid-binding protein 4 and that its level of expression in epicardials adipose tissues of metabolic syndrome patients is elevated.
86
Characterization of the Exon Structure of the Menkes Disease Gene Using Vectorette PCR
TL;DR: A preliminary comparison demonstrated a striking similarity between the exon structures of the Menkes and Wilson disease genes, giving insight into their evolution.
84
Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters.
Burçak Vural,Lin-Chi Chen M.D.,Pinar Saip,Yao-Tseng Chen,Zeki Ustuner,Mithat Gonen,Andrew J. G. Simpson,J. Lloyd Old,Ugur Ozbek,Ali O. Gure +9 more
TL;DR: Whether immune responses against neuroectodermal markers affect the clinical outcome in SCLC is critical in understanding the potential value of these proteins as cancer vaccine targets as well as in the pathogenesis of PND.
78
Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients.
Zeki Ustuner,Pinar Saip,Vildan Yasasever,Burçak Vural,Aziz Yazar,Cengiz Bal,Betul Ozturk,Ugur Ozbek,Erkan Topuz +8 more
TL;DR: Low serum VEGF concentration is a significant and independent prognostic factor in SCLC patients and its receptors VEGFR-1 and VEG FR-2 have value in detecting treatment modalities of SCLc need further studies.
42